Abstract
H. Lundbeck A/S is pleased to announce its agreement with the Danish Centre for Al Innovation (DCAI), the company established to run and operate Gefion, Denmark's flagship Al supercomputer. Lundbeck is one of the first pharmaceutical companies to leverage Gefion to accelerate drug discovery and development in neurological and psychiatric disorders.
Key Data
-
Publication Date06 May 2025
-
Primary AuthorLundbeck
-
SourceFirstWord HealthTech
-
LanguageEnglish
Click below to visit original source: